Halozyme Therapeutics | HALO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
Amgen USD 209.65B 14.21B 2026-08
Baxter International USD 11.01B 2.34B 2026-06
Cara Therapeutics USD 110M 80M 2026-08
Cytokinetics USD 9.6B 1.95B 2026-08
DBV Technologies USD 1.23B 327M 2026-03
Eli Lilly USD 1.11T 18.32B 2026-08
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
MannKind USD 1.11B 207M 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Pfizer USD 153.17B 14.73B 2026-08
United Therapeutics USD 24.42B 1.42B 2026-08
Vanda Pharmaceuticals USD 279M 6M 2024-12